Skip to main content
. 2017 Jun 8;30(2):122–139. doi: 10.1016/j.jsha.2017.05.001

Figure 1.

Figure 1

Net clinical benefit of non-vitamin K antagonist oral anticoagulants (NOACs) relative to vitamin K antagonists (VKAs). Note. From “New oral anticoagulant agents – general features and outcomes in subsets of patients,” by S. Schulman, 2014, Thromb Haemost, 111, p. 575–82. Copyright. Adapted with permission. HR = hazard ratio; RR = risk ratio; SE = systemic embolism.